A higher permeability and disrupted occludin, controlling intestinal barrier permeability, have been found in PD patients [25,26], which may lead to increased transition of pro-inflammatory cytokines that have been observed within the colon of patients with PD [24]. This evidence concerns the gene OCLN and Parkinson disease.